Karen’s Story: Bladder Cancer Nurse, Patient and Caregiver
Advertisement
In this very special episode of Bladder Cancer Matters, host Rick Bangs talks with Karen Sachse. Karen has a one-in-a-million perspective on bladder cancer because she is an oncology nurse, a nurse navigator, a bladder cancer survivor and was a caregiver to her husband, Roger, who passed away from the disease. She is also a very active patient advocate with the Bladder Cancer Advocacy Network.
Rick and Karen talk about:
Her bladder cancer diagnosis and treatment
Caring for her husband when he got bladder cancer
How her late husband benefited from BCAN’s programs and services
Why she participates in the Walks to End Bladder Cancer and thinks that others should too
In the phase 3 ASAC trial, daily aspirin did not lower the risk of colorectal cancer returning after treatment for liver metastases, and serious side effects were more common.
Challenge yourself after cancer by building healthier habits, strengthening relationships, managing stress and embracing new experiences for a healthier life.
Rinatabart sesutecan shrank tumors in 45.9% of patients with platinum-resistant ovarian cancer in a phase 2 study, with responses lasting a median of 12.1 months.
The FDA withdrew Zepzelca’s accelerated approval for small cell lung cancer after the LAGOON trial failed to show longer survival. Its maintenance use with Tecentriq is unaffected.
Liver and bile duct cancer treatment has changed quickly since 2021, with new immunotherapy combinations, targeted pills and a new radiation option. Here's what's been approved and what it means for patients.